ES2186694T3 - Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum. - Google Patents

Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum.

Info

Publication number
ES2186694T3
ES2186694T3 ES95105058T ES95105058T ES2186694T3 ES 2186694 T3 ES2186694 T3 ES 2186694T3 ES 95105058 T ES95105058 T ES 95105058T ES 95105058 T ES95105058 T ES 95105058T ES 2186694 T3 ES2186694 T3 ES 2186694T3
Authority
ES
Spain
Prior art keywords
treatment
necrophorum
bacterial vaccine
necrosis caused
hepatic necrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95105058T
Other languages
English (en)
Inventor
John N Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2186694T3 publication Critical patent/ES2186694T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO PARA EL TRATAMIENTO DEL GANADO VACUNO Y LANAR PARA PREVENIR LA NECROSIS DEL HIGADO, QUE COMPRENDE LA ADMINISTRACION DE UNA BACTERINA DE FUSOBACTERIUM NECROPHORUM.
ES95105058T 1990-06-07 1991-05-25 Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum. Expired - Lifetime ES2186694T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53489490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
ES2186694T3 true ES2186694T3 (es) 2003-05-16

Family

ID=24131961

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91108517T Expired - Lifetime ES2084057T3 (es) 1990-06-07 1991-05-25 Bacterina para el tratamiento de enfermedades causadas por f. necrophorum y procedimiento para su produccion.
ES95105058T Expired - Lifetime ES2186694T3 (es) 1990-06-07 1991-05-25 Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES91108517T Expired - Lifetime ES2084057T3 (es) 1990-06-07 1991-05-25 Bacterina para el tratamiento de enfermedades causadas por f. necrophorum y procedimiento para su produccion.

Country Status (8)

Country Link
US (1) US6132709A (es)
EP (2) EP0674905B1 (es)
AU (1) AU644440B2 (es)
CA (1) CA2043932C (es)
DE (2) DE69133172T2 (es)
ES (2) ES2084057T3 (es)
IE (1) IE72181B1 (es)
NZ (1) NZ238378A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149821T3 (es) * 1992-06-26 2000-11-16 Univ Kansas State Vacuna leucotoxoide de fusobacterium necrophorum.
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
WO1996040237A1 (en) * 1995-06-07 1996-12-19 Kansas State University Research Foundation Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
US5861162A (en) * 1995-06-07 1999-01-19 Kansas State University Research Foundation Multivalent inocula for lessening incidence of liver abscesses in cattle
US6632439B2 (en) 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
RU2520082C2 (ru) * 2008-01-18 2014-06-20 Вернер ЛЮБИТЦ Способ получения "теней"бактериальных клеток (bg)
IN2012DN03418A (es) 2009-10-09 2015-10-23 Childrens Medical Center
JP6301945B2 (ja) 2012-11-29 2018-03-28 コーネル ユニバーシティＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 子宮内疾患のためのワクチン
WO2025160664A1 (en) * 2024-01-31 2025-08-07 University Of Saskatchewan Methods and uses of fusobacterium necrophorum immunogenic compositions and vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA984293A (en) * 1971-08-20 1976-02-24 Richard W. Moore Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom
FR2174745A1 (en) * 1972-03-09 1973-10-19 Inst Elevage Med Vet Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
US4061751A (en) * 1976-07-22 1977-12-06 American Cyanamid Company 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of foot rot and liver lesions in ruminant animals
US4203968A (en) * 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
DE3852918T2 (de) * 1987-09-28 1995-07-13 Beecham Inc TGEV-Virus vom Schwein als Impfstoff für Hunde.

Also Published As

Publication number Publication date
EP0460480A2 (en) 1991-12-11
EP0460480A3 (en) 1992-04-01
EP0674905B1 (en) 2002-12-11
ES2084057T3 (es) 1996-05-01
AU644440B2 (en) 1993-12-09
EP0460480B1 (en) 1996-01-24
IE911940A1 (en) 1991-12-18
CA2043932C (en) 2006-09-12
AU7817791A (en) 1991-12-12
NZ238378A (en) 1992-12-23
CA2043932A1 (en) 1991-12-08
EP0674905A2 (en) 1995-10-04
EP0674905A3 (en) 1995-12-06
DE69116606D1 (de) 1996-03-07
DE69133172D1 (de) 2003-01-23
IE72181B1 (en) 1997-03-26
US6132709A (en) 2000-10-17
DE69133172T2 (de) 2003-04-30
DE69116606T2 (de) 1996-05-30

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2170771T3 (es) Atenuacion de un epitopo inmunodominante de un antigeno para su utilizacion en vacunas e inmunoterapias para vegetales, animales y humanos.
GT200300180A (es) Vacunas para enfermedades reproductoras del ganado
ES2052495T3 (es) Terapia de fluidos con aniones l-lactato y/o piruvato.
CO5221085A1 (es) Mejoramiento de la condicion de mascotas anosas
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ECSP941111A (es) Nuevas sulfonilaminopirimidinas,
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
ES2133311T3 (es) Vacunas antifertilidad de salmonella avirulenta recombinante.
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
GT200000183A (es) Aminoacidos biciclicos como agentes farmaceuticos.
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
MX9201058A (es) Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.
PE3096A1 (es) Formulacion conteniendo selenio
ES2078507T3 (es) Medicinas y derivados de sulfonanilida.
ES2095861T3 (es) Composiciones con antibioticos estabilizadas para la alimentacion animal.
ES2045348T3 (es) Metodo para preparar derivados de lactamimida para el tratamiento o la prevencion de paludismo farmaco-resistente.
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.